Почетна › Колоректални карцином › Nebraska › Omaha
Kliničke studije za Колоректални карцином u gradu Omaha, NE
18 studija za Колоректални карцином traži učesnike na lokacijama u gradu Omaha i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Zanzalintinib Alone or in Combination With Pembrolizumab and Berahyaluronidase Alfa in Participants With Colorectal Cancer With Molecular Residual Disease
Тражи се учесникФаза 3
- Oncology Hematology West, PC dba Nebraska Cancer Specialists - Methodist, Omaha
- Oncology Hematology West, PC dba Nebraska Cancer Specialists - Bergan, Omaha
- Oncology Hematology West, PC dba Nebraska Cancer Specialists - Legacy, Omaha
- и још 2
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
Тражи се учесникФаза 3Здраве особе су добродошле
- Alegent Health Immanuel Medical Center, Omaha
- Alegent Health Bergan Mercy Medical Center, Omaha
- Alegent Health Lakeside Hospital, Omaha
- и још 1
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
- Alegent Health Immanuel Medical Center, Omaha
- Alegent Health Bergan Mercy Medical Center, Omaha
- Alegent Health Lakeside Hospital, Omaha
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Тражи се учесникФаза 3
- Nebraska Cancer Specialists Midwest Cancer Center, Omaha
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Тражи се учесникФаза 3
- Nebraska Cancer Specialists, Omaha
Family Communications After Genetic Testing
Тражи се учесникЗдраве особе су добродошле
- Alegent Health Immanuel Medical Center, Omaha
- Alegent Health Bergan Mercy Medical Center, Omaha
- Alegent Health Lakeside Hospital, Omaha
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
Тражи се учесникФаза 2
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
- Nebraska Medicine-Bellevue, Bellevue · 9 ми удаљено
A Study to Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC)
Тражи се учесникФаза 1
- Nebraska Cancer Specialists, Omaha
Lead-212 PSV359 Therapy for Patients With Solid Tumors
Тражи се учесникФаза 1/2
- Nebraska Cancer Specialists, Omaha
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
Тражи се учесникФаза 2
- Nebraska Cancer Specialists - Omaha - Wright Street /ID# 271646, Omaha
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
Тражи се учесникФаза 2/3
- University Of Nebraska Medical Center, Omaha
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Тражи се учесникФаза 1
- Exelixis Clinical Site #2, Omaha
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
Тражи се учесникФаза 1/2
- Nebraska Cancer Specialists, Omaha
- XCancer, Omaha
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Тражи се учесникФаза 1/2
- Nebraska Cancer Specialists, Omaha
- University of Nebraska Medical Center, Omaha
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
Тражи се учесникФаза 2
- Nebraska Cancer Specialists, Omaha
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Тражи се учесникФаза 1
- Nebraska Cancer Specialists (Midwest Cancer Center - Legacy), Omaha
- XCancer Omaha / Urology Cancer Center, Omaha
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1/2
- Nebraska Cancer Specialists, Omaha
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
Тражи се учесникОпсервациона студија
- Nebraska Cancer Specialists, Omaha
Studije za Колоректални карцином u drugim gradovima
- Houston, TX101 студија
- New York City, NY86 студија
- Nashville, TN67 студија
- Boston, MA62 студија
- Los Angeles, CA61 студија
- Arlington, VA54 студија
- St. Louis, MO51 студија
- San Antonio, TX43 студија
- Philadelphia, PA41 студија
- Grand Rapids, MI40 студија
- Baldwin Park, CA37 студија
- Tampa, FL36 студија
Ostale studije u gradu Omaha
- Рак простате29 студија
- Немалоклетни карцином плућа25 студија
- Рак дојке23 студија
- Рак (све врсте)19 студија
- Многи мијелом17 студија
- Рак јајника15 студија
- Рак панкреаса15 студија
- Плоскоклеточни карцином главе и врата15 студија
- Метастатски карцином14 студија
- Не-Ходжкинов лимфом14 студија
- Рак плућа13 студија
- Рак бубрега (карцином бубрежних ћелија)12 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.